VEGFB and neoplasm: In conclusion, we found that treatment of mouse breast and colon xenograft models with anti-VEGF-B antibody 2H10 resulted in reduced tumor growth, associated with decreased density and dilation of the tumor vasculature, and reduced fluid accumulation.